UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

Gene therapy, 2002-01, Vol.9 (2), p.127-134

2002

Link zum Volltext

Verfügbarkeit prüfen

P2.07-059 Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (GMCI) for Malignant Pleural Effusion (MPE) and Malignant Pleural Mesothelioma (MPM)

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2151-S2152

2017

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Molecular therapy, 2001-04, Vol.3 (4), p.536-542

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of gene-mediated cytotoxic immunotherapy in combination with chemoradiation for locally advanced pancreatic cancer

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.195-195

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial evaluating combined radiotherapy and in-situ gene therapy with or without hormonal therapy in the treatment of prostate cancer-an interim report on PSA response and biopsy data

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.138-138

2002

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

Cancer gene therapy, 2002-05, Vol.9 (5), p.478-481

2002

Link zum Volltext

Verfügbarkeit prüfen

2188

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S314

2006

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the role of 5′ regulatory mutations in the activation of quiescent metallothionein genes after carcinogen treatment

Gene expression, 1991, Vol.1 (3), p.217-221

1991

Link zum Volltext

Verfügbarkeit prüfen

Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (4), p.1008-1017

2001

Link zum Volltext

Verfügbarkeit prüfen

Five year follow up of a phase II study of cytotoxic immunotherapy combined with radiation in newly diagnosed prostate cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.4635-4635

2006

Link zum Volltext

Verfügbarkeit prüfen

Radiographic and immunologic responses to adjuvant immunotherapy for malignant gliomas

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2039-2039

2008

Link zum Volltext

Verfügbarkeit prüfen

2188: Long Term Biochemical Outcome of a Phase I-II Trial Evaluating Cytotoxic Immuno-Genetherapy in Combination With IMRT in Newly Diagnosed Prostate Cancer

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S314-S314

2006

Link zum Volltext

Verfügbarkeit prüfen

Coinjection strategy for visual identification of transgenic mice

Transgenic research, 1991-12, Vol.1 (1), p.31-37

1991

Link zum Volltext

Verfügbarkeit prüfen

2193

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S316-S317

2006

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: Expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5

Journal of the Society for Gynecologic Investigation, 2002-06, Vol.9 (3), p.174-180

2002

Link zum Volltext

Verfügbarkeit prüfen

2193: Long-Term T Cell Activation Following Combined In Situ Gene Therapy and Intensity-Modulated Radiotherapy Compared to Gene Therapy as Mono-Therapy in Prostate Cancer Patients

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S316-S317

2006

Link zum Volltext

Verfügbarkeit prüfen

Sustained Long-term Immune Responses Following In Situ Gene Therapy Combined with Radiotherapy and Hormonal Therapy in Prostate Cancer Patients

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S299-S300

2005

Link zum Volltext

Verfügbarkeit prüfen

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4571-4571

2004

Link zum Volltext

Verfügbarkeit prüfen

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4571-4571

2004

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity and reproducibility in adenoviral infectious titer determination

Nature medicine, 1997-07, Vol.3 (7), p.808-811

1997

Link zum Volltext

Verfügbarkeit prüfen

Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene: Gene therapy in urologic oncology

World journal of urology, 2000, Vol.18 (2), p.125-129

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial evaluating combined radiotherapy and in-situ gene-therapy with or without hormonal therapy in the treatment of prostate cancer - a preliminary report

International journal of radiation oncology, biology, physics, 2000, Vol.48 (3), p.171-172

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors

Molecular therapy, 2000-02, Vol.1 (2), p.195

2000

Link zum Volltext

Verfügbarkeit prüfen

Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressing alpha sub(1)-Antitrypsin after Systemic Delivery

Human gene therapy, 1998-07, Vol.9 (11), p.1587-1598

1998

Link zum Volltext

Verfügbarkeit prüfen

Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery

Human gene therapy, 1998-07, Vol.9 (11), p.1587

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieNeuro-Oncology

ThemaScience & Technology

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(72)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

P2.07-059 Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (GMCI) for Malignant Pleural Effusion (MPE) and Malignant Pleural Mesothelioma (MPM)

Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Phase I trial of gene-mediated cytotoxic immunotherapy in combination with chemoradiation for locally advanced pancreatic cancer

Phase I/II trial evaluating combined radiotherapy and in-situ gene therapy with or without hormonal therapy in the treatment of prostate cancer-an interim report on PSA response and biopsy data

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

2188

Analysis of the role of 5′ regulatory mutations in the activation of quiescent metallothionein genes after carcinogen treatment

Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model

Five year follow up of a phase II study of cytotoxic immunotherapy combined with radiation in newly diagnosed prostate cancer

Radiographic and immunologic responses to adjuvant immunotherapy for malignant gliomas

2188: Long Term Biochemical Outcome of a Phase I-II Trial Evaluating Cytotoxic Immuno-Genetherapy in Combination With IMRT in Newly Diagnosed Prostate Cancer

Coinjection strategy for visual identification of transgenic mice

2193

Adenovirus-mediated thymidine kinase gene therapy for recurrent ovarian cancer: Expression of coxsackie-adenovirus receptor and integrins αvβ3 and αvβ5

2193: Long-Term T Cell Activation Following Combined In Situ Gene Therapy and Intensity-Modulated Radiotherapy Compared to Gene Therapy as Mono-Therapy in Prostate Cancer Patients

Sustained Long-term Immune Responses Following In Situ Gene Therapy Combined with Radiotherapy and Hormonal Therapy in Prostate Cancer Patients

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

PSA nadir and 24 month biopsy interim analysis of AdV-tk/Valacyclovir gene therapy in combination with radiotherapy vs radiotherapy alone for prostate cancer

Sensitivity and reproducibility in adenoviral infectious titer determination

Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene: Gene therapy in urologic oncology

Phase I/II trial evaluating combined radiotherapy and in-situ gene-therapy with or without hormonal therapy in the treatment of prostate cancer - a preliminary report

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors

Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressing alpha sub(1)-Antitrypsin after Systemic Delivery

Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery

Aktive Filter

Suchergebnisse filtern